MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Mohammed Eslam, Jacob George, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):150-163.   Published online 2021 Nov 10     DOI: https://doi.org/10.3350/cmh.2021.0310
Citations to this article as recorded by Crossref logo
Metabolic dysfunction-associated fatty liver disease — How relevant is this to primary care physicians and diabetologists?
Chi-Ho Lee
Primary Care Diabetes.2022;[Epub]     CrossRef
Atherosclerotic cardiovascular disease in non‐metabolic nonalcoholic fatty liver disease
Tsubasa Tsutsumi, Takumi Kawaguchi, Dan Nakano, Takuji Torimura
Hepatology Research.2022; 52(3): 317.     CrossRef
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clinical and Molecular Hepatology.2022; 28(2): 269.     CrossRef